Actavis, NY AG Differ On Suboxone Ruling On Antitrust Suit
The New York attorney general and Actavis PLC have continued their battle over a bid to block Actavis from pulling its popular dementia drug Namenda from the market until the conclusion...To view the full article, register now.
Already a subscriber? Click here to view full article